MilWealth Group’s Abbott ABT Stock Holding History

MilWealth Group’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-135	Closed	-$19K	–	81
2021 Q4	$19K	Hold	135	–	–	0.01%	58
2021 Q3	$15.9K	Buy	+135	New	+$16.6K	0.01%	65

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MilWealth Group's ABT Position: Q1 2022 in Review

MilWealth Group sold out of Abbott (ABT) in Q1 2022, closing a stake of 135 shares — an estimated $19K sold.

MilWealth Group first reported a position in ABT in Q3 2021 and held it in 2 quarters. The position peaked at $19K in Q4 2021. 2,760 funds tracked by Wall St. Rank hold ABT as of Q1 2022.

MilWealth Group reported no remaining Abbott position as of Q1 2022 after selling out during the quarter.
MilWealth Group sold 135 Abbott shares in Q1 2022, an estimated $19K.
MilWealth Group first reported a position in Abbott in Q3 2021 and held it in 2 quarters.
MilWealth Group's Abbott position peaked at $19K in Q4 2021.
2,760 funds tracked by Wall St. Rank held Abbott as of Q1 2022.

Based on MilWealth Group's 13F filing for Q1 2022, filed 9 May 2023.